Biopharma start-ups brought in nearly two-and-a-half times as much funding in the fourth quarter as in the third quarter. Novartis AG was one of five big pharma companies to pen an alliance with a new and emerging therapeutics firm; the company also signed an acquisition.
Biopharma start-ups raised a total of $2bn during the final quarter of 2016, which was a significant increase from the...